Longwei Zhao

465 total citations
13 papers, 347 citations indexed

About

Longwei Zhao is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Longwei Zhao has authored 13 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Longwei Zhao's work include Fibroblast Growth Factor Research (8 papers), Epigenetics and DNA Methylation (3 papers) and Phagocytosis and Immune Regulation (2 papers). Longwei Zhao is often cited by papers focused on Fibroblast Growth Factor Research (8 papers), Epigenetics and DNA Methylation (3 papers) and Phagocytosis and Immune Regulation (2 papers). Longwei Zhao collaborates with scholars based in China, United States and Hong Kong. Longwei Zhao's co-authors include Xiaokun Li, Zhifeng Huang, Moosa Mohammadi, Lintao Song, Yi Tan, Zilu Chen, Jun-Jun Xie, Guanghui Zhu, Guang Liang and Qian Lin and has published in prestigious journals such as Nature Communications, Kidney International and British Journal of Pharmacology.

In The Last Decade

Longwei Zhao

12 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Longwei Zhao China	8	250	46	40	37	33	13	347
Seul-Ki Lim South Korea	10	265 1.1×	41 0.9×	62 1.6×	48 1.3×	25 0.8×	14	477
I-K Lee South Korea	8	156 0.6×	57 1.2×	76 1.9×	46 1.2×	36 1.1×	8	374
Yingfeng Tu China	11	217 0.9×	44 1.0×	59 1.5×	29 0.8×	11 0.3×	18	385
Manhua Chen China	11	209 0.8×	99 2.2×	28 0.7×	47 1.3×	15 0.5×	15	341
Xiaoting Xi China	10	263 1.1×	63 1.4×	24 0.6×	37 1.0×	20 0.6×	15	398
Tamadher A. Alghamdi Canada	10	227 0.9×	77 1.7×	41 1.0×	38 1.0×	99 3.0×	12	451
Zhengyang Bao China	12	182 0.7×	53 1.2×	35 0.9×	127 3.4×	59 1.8×	22	364
Pradeep Bompada Sweden	8	201 0.8×	26 0.6×	110 2.8×	53 1.4×	40 1.2×	11	347
Michael Föller Germany	10	222 0.9×	26 0.6×	44 1.1×	17 0.5×	109 3.3×	10	392

Countries citing papers authored by Longwei Zhao

Since Specialization

Citations

This map shows the geographic impact of Longwei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longwei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longwei Zhao more than expected).

Fields of papers citing papers by Longwei Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longwei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longwei Zhao. The network helps show where Longwei Zhao may publish in the future.

Co-authorship network of co-authors of Longwei Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Longwei Zhao. A scholar is included among the top collaborators of Longwei Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longwei Zhao. Longwei Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ye, X., Yanqun Dong, Jiapeng Han, et al.. (2025). Repurposing zafirlukast confers renal protection in ischemia-reperfusion injury via suppressing macrophage METosis. International Immunopharmacology. 165. 115459–115459. 1 indexed citations

Yang, Nanfei, Qiang Tian, Shuxin Wang, et al.. (2025). FGF2 Mediated USP42‐PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration. Advanced Science. 12(18). e2408724–e2408724.

Xu, Lingxiao, et al.. (2025). Laminaran potentiates cGAS-STING signaling to enhance antiviral responses. International Immunopharmacology. 147. 114014–114014. 4 indexed citations

Feng, Shuang, Heng Zheng, Ying Xia, et al.. (2025). FGF1^ΔHBS ameliorates DSS‐induced ulcerative colitis by reducing neutrophil recruitment through the MAPK pathway. British Journal of Pharmacology. 182(20). 5057–5070. 1 indexed citations

Sun, Peng, Jiaxi Ru, Xiaoyan Li, et al.. (2024). Nano-carrier DMSN for effective multi-antigen vaccination against SARS-CoV-2. Journal of Nanobiotechnology. 22(1). 11–11. 4 indexed citations

Ye, Xiaochun, Peng Sun, Fan Xia, et al.. (2023). Fgf21-Dubosiella axis mediates the protective effects of exercise against NAFLD development. Life Sciences. 334. 122231–122231. 22 indexed citations

Lei, Ying, Luyao Wang, Kaiwen Guo, et al.. (2021). Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects. Nature Communications. 12(1). 7256–7256. 54 indexed citations

Zhao, Longwei, et al.. (2020). Fibroblast growth factor 1 ameliorates adipose tissue inflammation and systemic insulin resistance via enhancing adipocyte mTORC2/Rictor signal. Journal of Cellular and Molecular Medicine. 24(21). 12813–12825. 14 indexed citations

Zhao, Longwei, Yang Liu, Xiaojie Wang, et al.. (2019). Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases. EBioMedicine. 48. 462–477. 20 indexed citations

10.

Zhao, Longwei, Shuang Feng, Shen Wang, et al.. (2019). Production of bioactive recombinant human myeloid‐derived growth factor in Escherichia coli and its mechanism on vascular endothelial cell proliferation. Journal of Cellular and Molecular Medicine. 24(2). 1189–1199. 13 indexed citations

11.

Liang, Guang, Lintao Song, Zilu Chen, et al.. (2017). Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. Kidney International. 93(1). 95–109. 124 indexed citations

12.

Huang, Zhifeng, Yi Tan, Junlian Gu, et al.. (2017). Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability. Cell Reports. 20(7). 1717–1728. 71 indexed citations

13.

Zhao, Longwei, et al.. (2017). Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice. BMC Biotechnology. 17(1). 58–58. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact